Contact Us

SEC Filings

Investor Contacts

Jeff Macdonald
Executive Director,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Mar 06, 2013	4/A	Amendment to a previously filed 4	3,4,5	View HTML 0001232524-13-000024.pdf 0001232524-13-000024.rtf
Mar 05, 2013	FWP	FWP	Other	View HTML 0001193125-13-090091.pdf 0001193125-13-090091.rtf 0001193125-13-090091.xls
Mar 05, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-13-000013.pdf 0001232524-13-000013.rtf
Mar 04, 2013	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-13-089742.pdf 0001193125-13-089742.rtf 0001193125-13-089742.xls
Feb 27, 2013	S-8	Securities offered to employees pursuant to employee benefit plans	Registration Statements	View HTML 0001193125-13-077425.pdf 0001193125-13-077425.rtf 0001193125-13-077425.xls
Feb 27, 2013	IRANNOTICE	Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act	Other	View HTML 0001232524-13-000011.pdf 0001232524-13-000011.rtf 0001232524-13-000011.xls
Feb 26, 2013	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-13-077015.pdf 0001193125-13-077015.rtf 0001193125-13-077015.xls
Feb 26, 2013	10-K	Annual report which provides a comprehensive overview of the company for the past year	Annual Filings	View HTML 0001232524-13-000010.pdf 0001232524-13-000010.rtf 0001232524-13-000010.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Feb 20, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001144204-13-010336.pdf 0001144204-13-010336.rtf
Feb 20, 2013	CORRESP	CORRESP	Other	View HTML 0001193125-13-066869.pdf 0001193125-13-066869.rtf 0001193125-13-066869.xls

Data provided by Kaleidoscope.